Zoetis Inc. is a global leader in animal health, dedicated to supporting the health and well-being of animals through innovative products and services. The company's mission is to empower veterinarians and livestock producers with solutions that enhance animal health and productivity. Zoetis focuses on research and development to create a diverse portfolio of vaccines, medicines, and diagnostic tools for both companion animals and livestock. Its strategy emphasizes sustainability, collaboration with stakeholders, and leveraging advanced technologies to meet the evolving needs of the animal health market, ultimately improving the quality of life for animals and the people who care for them.

ZOETIS INC

Zoetis Inc. (ZTS) has been facing significant investor challenges, with its stock price dropping over 7% recently following its forecast for full-year adjusted earnings per share (EPS). The company has projected its EPS to fall between $6.00 and $6.10, which is notably below the consensus estimate of $6.28.

Zoetis Shares Fall Over 7% After Lowered Earnings Forecast Below Market Expectations

Zoetis Inc. faces a challenging landscape as its stock tumbles over 7% following a disappointing earnings forecast, falling short of market expectations. With the animal health sector's resilience in question, can Zoetis regain investor confidence and turn this setback into a growth opportunity?